5 results on '"AZEVEDO, Ana"'
Search Results
2. Effectiveness of nirsevimab introduction against respiratory syncytial virus in the Valencian Community: A preliminary assessment.
- Author
-
Estrella-Porter P, Blanco-Calvo C, Lameiras-Azevedo AS, Juaneda J, Fernández-Martínez S, Gómez-Pajares F, Tempelsman R, Roig-Sena FJ, Pérez-Panades J, Botella-Rocamora P, Lluch-Rodrigo JA, and Pastor-Villalba E
- Subjects
- Humans, Infant, Spain epidemiology, Female, Male, Child, Preschool, Pre-Exposure Prophylaxis methods, Antiviral Agents therapeutic use, Antiviral Agents administration & dosage, Incidence, Respiratory Syncytial Virus Infections prevention & control, Respiratory Syncytial Virus Infections epidemiology, Respiratory Syncytial Virus Infections immunology, Antibodies, Monoclonal, Humanized therapeutic use, Antibodies, Monoclonal, Humanized administration & dosage, Respiratory Syncytial Virus, Human immunology, Hospitalization statistics & numerical data
- Abstract
Respiratory syncytial virus (RSV) represents a high burden of disease in children and the primary cause of hospitalization, especially in children under 1 year old. In the Valencian Community (Spain), nirsevimab, a long-acting monoclonal antibody, was introduced for the RSV 2023-2024 season as a universal pre-exposure prophylaxis for high-risk children and those under 6 months old. This study examines its impact, coverage, and effectiveness. The campaign achieved 88.5 % coverage and 73.7 % of effectiveness. Analysis of over 27,000 susceptible children (over 24,000 immunized), showed that those immunized exhibited a threefold reduction in RSV incidence compared to non-immunized ones. To prevent one case, the number needed to immunize (NNI) was 63. Hospitalizations due to acute respiratory infections were almost two times lower in immunized children compared to non-immunized ones (0.9 % vs 1.6 %, respectively). These first results showcase the preliminary positive impact of this public health intervention., Competing Interests: Declaration of competing interest The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper., (Copyright © 2024 Elsevier Ltd. All rights reserved.)
- Published
- 2024
- Full Text
- View/download PDF
3. Severity of respiratory syncytial virus compared with SARS-CoV-2 and influenza among hospitalised adults ≥65 years.
- Author
-
Vega-Piris L, Carretero SG, Mayordomo JL, Zarzuelo MBR, Río VÁ, García VG, Vázquez MG, Rodríguez MDCG, Basile L, González-Coviella NL, Boada MIB, Pérez-Martínez O, Azevedo AL, Rubio CQ, Duran JG, Ibáñez AF, Rivera MVG, Marín VR, Castrillejo D, Raymundo LJV, Larrauri A, and Monge S
- Subjects
- Humans, Aged, Male, Female, Aged, 80 and over, Spain epidemiology, Hospital Mortality, Severity of Illness Index, Respiratory Syncytial Virus, Human isolation & purification, COVID-19 epidemiology, COVID-19 mortality, Influenza, Human epidemiology, Influenza, Human mortality, Influenza, Human virology, Hospitalization statistics & numerical data, SARS-CoV-2, Respiratory Syncytial Virus Infections epidemiology, Respiratory Syncytial Virus Infections mortality, Intensive Care Units statistics & numerical data
- Abstract
Introduction: Our aim was to estimate the risk of pneumonia, admission to intensive care unit (ICU) or death in individuals ≥65 years old admitted to hospital with RSV, compared to influenza or COVID-19., Methods: We included hospitalised patients from Severe Acute Respiratory Infection Surveillance in Spain between 2021-2024, aged ≥65 years, laboratory confirmed for RSV, influenza or SARS-CoV-2. Using a binomial regression with logarithmic link, we estimated the relative risk (RR) of pneumonia, ICU admission and in-hospital mortality, in patients with RSV compared to influenza or SARS-CoV-2, adjusting for age, sex, season and comorbidities. We stratified the estimates by vaccination status for influenza or SARS-CoV2., Results: Among patients unvaccinated for influenza or SARS-CoV-2, those with RSV had similar or lower risk of pneumonia [vs. influenza: RR= 0.91 (95% Confidence Interval: 0.72-1.16); vs. SARS-CoV-2: 0.81 (0.67-0.98)], ICU admission [vs. influenza: 0.93 (0.41-2.08); vs. SARS-CoV-2: 1.10 (0.61-1.99)] and mortality [vs. influenza: 0.64 (0.32-1.28); vs. SARS-CoV-2: 0.56 (0.30-1.04)]. Among the vaccinated, results were largely similar except for a higher risk of ICU admission with RSV [vs. influenza: 2.13(1.16-3.89); vs. SARS-CoV-2: 1.83 (1.02-3.28)] CONCLUSIONS: RSV presented similar or lower intrinsic severity than influenza or SARS-CoV2. Among vaccinated patients, RSV was associated to higher ICU-admission, suggesting the potential for preventive RSV vaccination., Competing Interests: Declaration of Competing Interest The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper., (Copyright © 2024 The Authors. Published by Elsevier Ltd.. All rights reserved.)
- Published
- 2024
- Full Text
- View/download PDF
4. Effectivity of a Program for the Control and Prevention of COVID-19 Healthcare-Associated Infections in a Spanish Academic Hospital.
- Author
-
Gras-Valentí P, Mora-Muriel JG, Chico-Sánchez P, Algado-Sellés N, Soler-Molina VM, Hernández-Maldonado M, Lameiras-Azevedo AS, Jiménez Sepúlveda NJ, Gómez Sotero IL, Villanueva-Ruiz CO, Barrenengoa-Sañudo J, Fuster-Pérez M, Cánovas-Jávega S, Cerezo-Milan P, Monerris-Palmer M, Llorens-Soriano P, Merino-Lucas E, Rodríguez-Diaz JC, Gil-Carbonell J, Sánchez-Martínez R, Pastor-Cesteros R, Mena-Esquivias L, Galiana-Ivars M, Jaime-Sánchez FA, Margarit-Ferri C, Gonzalez-deDios J, Lloret G, García-Alonso MA, Sánchez-Vela P, and Sánchez-Payá J
- Subjects
- Adult, COVID-19 epidemiology, COVID-19 transmission, Cross Infection epidemiology, Female, Humans, Incidence, Infectious Disease Transmission, Patient-to-Professional statistics & numerical data, Male, Masks statistics & numerical data, Middle Aged, Personnel, Hospital statistics & numerical data, Program Evaluation, Risk Assessment statistics & numerical data, SARS-CoV-2 isolation & purification, Spain epidemiology, Academic Medical Centers, COVID-19 prevention & control, Cross Infection prevention & control, Infectious Disease Transmission, Patient-to-Professional prevention & control
- Abstract
Background: Although recommendations to prevent COVID-19 healthcare-associated infections (HAIs) have been proposed, data on their effectivity are currently limited., Objective: The aim was to evaluate the effectivity of a program of control and prevention of COVID-19 in an academic general hospital in Spain., Methods: We captured the number of COVID-19 cases and the type of contact that occurred in hospitalized patients and healthcare personnel (HCP). To evaluate the impact of the continuous use of a surgical mask among HCP, the number of patients with COVID-19 HAIs and accumulated incidence of HCP with COVID-19 was compared between the preintervention and intervention periods., Results: Two hundred fifty-two patients with COVID-19 have been admitted to the hospital. Seven of them had an HAI origin (6 in the preintervention period and 1 in the intervention period). One hundred forty-two HCP were infected with SARS-CoV-2. Of them, 22 (15.5%) were attributed to healthcare (2 in the emergency department and none in the critical care departments), and 120 (84.5%) were attributed to social relations in the workplace or during their non-work-related personal interactions. The accumulated incidence during the preintervention period was 22.3 for every 1000 HCP and 8.2 for every 1000 HCP during the intervention period. The relative risk was 0.37 (95% confidence interval, 0.25 to 0.55) and the attributable risk was -0.014 (95% confidence interval, -0.020 to -0.009)., Conclusions: A program of control and prevention of HAIs complemented with the recommendation for the continuous use of a surgical mask in the workplace and social environments of HCP effectively decreased the risk of COVID-19 HAIs in admitted patients and HCP., Competing Interests: The authors disclose no conflict of interest., (Copyright © 2021 The Author(s). Published by Wolters Kluwer Health, Inc.)
- Published
- 2021
- Full Text
- View/download PDF
5. Frequency, Associated Risk Factors, and Characteristics of COVID-19 Among Healthcare Personnel in a Spanish Health Department.
- Author
-
Algado-Sellés N, Gras-Valentí P, Chico-Sánchez P, Mora-Muriel JG, Soler-Molina VM, Hernández-Maldonado M, Lameiras-Azevedo AS, Jiménez-Sepúlveda NJ, Gómez-Sotero IL, Villanueva-Ruiz CO, Barrenengoa-Sañudo J, Fuster-Pérez M, Cánovas-Javega S, Cerezo-Milan P, Monerris-Palmer M, Esclapez A, Cartagena-Llopis L, García-Rivera C, Martínez-Tornero I, Nadal-Morante V, Merino-Lucas E, Rodriguez-Diaz JC, Vidal-Catala I, Llorens-Soriano P, San Inocencio D, Gil-Carbonell J, Montiel-Higuero I, Sánchez-Vela P, and Sánchez-Payá J
- Subjects
- Adult, Age Factors, Aged, COVID-19, Contact Tracing methods, Female, Humans, Male, Middle Aged, Occupations, Pandemics, Public Health Surveillance methods, Risk Factors, SARS-CoV-2, Severity of Illness Index, Sex Factors, Spain epidemiology, Tertiary Care Centers, Coronavirus Infections epidemiology, Health Personnel statistics & numerical data
- Abstract
Introduction: This study examines the frequency, associated factors, and characteristics of healthcare personnel coronavirus disease 2019 cases in a healthcare department that comprises a tertiary hospital and its associated 12 primary healthcare centers., Methods: This study included healthcare personnel that showed symptoms or were in contact with a coronavirus disease 2019 case patient from March 2, 2020 to April 19, 2020. Their evolution and characteristics (age, sex, professional category, type of contact) were recorded. Correlations between the different characteristics and risk of developing coronavirus disease 2019 and severe coronavirus disease 2019 were analyzed using chi-square tests. Their magnitudes were quantified with ORs, AORs, and their 95% CIs using a logistic regression model., Results: Of the 3,900 healthcare professionals in the department, 1,791 (45.9%) showed symptoms or were part of a contact tracing study. The prevalence of those with symptoms was 20.1% (784/3,900; 95% CI=18.8, 21.4), with coronavirus disease 2019 was 4.0% (156/3,900; 95% CI=3.4, 4.6), and with severe coronavirus disease 2019 was 0.5% (18/3,900; 95% CI=0.2, 0.7). The frequency of coronavirus disease 2019 in symptomatic healthcare personnel with a nonprotected exposure was 22.8% (112/491) and 13.7% (40/293) in those with a protected exposure (AOR=2.2, 95% CI=1.2, 3.9). The service in which the healthcare personnel performed their activity was not significantly associated with being diagnosed with coronavirus disease 2019. A total of 26.3% (10/38) of male healthcare personnel with coronavirus disease 2019 required hospitalization, compared with 6.8% (8/118) among female healthcare personnel (OR=4.9, 95% CI=1.8, 13.6)., Conclusions: A surveillance and monitoring program centred on healthcare personnel enables an understanding of the risk factors that lead to coronavirus disease 2019 among this population. This knowledge allows the refinement of the strategies for disease control and prevention in healthcare personnel during the coronavirus disease 2019 pandemic., (Copyright © 2020 American Journal of Preventive Medicine. Published by Elsevier Inc. All rights reserved.)
- Published
- 2020
- Full Text
- View/download PDF
Catalog
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.